Vitro Overview

  • Year Founded
  • 1989

Year Founded

  • Status
  • Private

  • Employees
  • 225

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 2

  • Investments
  • 3

Vitro General Information

Description

Manufacturer, developer and distributor of equipment, software and reagents for the health industry. The company offers solutions for in-vitro diagnosis through the application of techniques based on non-invasive tests such as immunohistochemistry and biology as well as develops and markets various software programs for pathology laboratories, enabling clients to meet their diagnostics reagents, equipment and software needs.

Contact Information

Website
www.vitro.bio
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Nudo Norte Building (local 3)
  • Luis Fuentes Bejarano Street 60
  • 41020 Sevilla
  • Spain
+34 954
Primary Industry
Other Devices and Supplies
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • Nudo Norte Building (local 3)
  • Luis Fuentes Bejarano Street 60
  • 41020 Sevilla
  • Spain
+34 954

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vitro Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Vitro‘s full profile, request access.

Request a free trial

Vitro Patents

  • 72

    Total Documents Applications and Grants

  • Total Patents Families

  • 19

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

Vitro Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2987402-A1 Computer-implemented method and system for performing histological stains, immuno-enzymatic stains and hybridation on tissue sections or cellular spreads and apparatus for carrying them out (machine-translation by google translate, not legally binding) Inactive 21-Apr-2023
EP-4345173-A1 A method, uses, system and kit for detecting a human papillomavirus genotype associated with development of cervical, oral or anogenital cancer in a subject and for determining the genotype or genotypes thereof Inactive 30-Sep-2022
EP-4547871-A1 A method, uses, system and kit for detecting a human papillomavirus genotype associated with development of cervical, oral or anogenital cancer in a subject and for determining the genotype or genotypes thereof Pending 30-Sep-2022
ES-1287787-U Isolated biological samples collection device (machine-translation by google translate, not legally binding) Active 07-Feb-2022
ES-1287787-Y Isolated biological samples collection device Active 07-Feb-2022 B01L3/508
To view Vitro’s complete patent history, request access »

Vitro Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vitro Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Vitro‘s full profile, request access.

Request a free trial

Vitro Investments & Acquisitions (3)

Vitro’s most recent deal was a Merger/Acquisition with Recovid Solutions for . The deal was made on 01-Jan-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Recovid Solutions 01-Jan-2022 Merger/Acquisition Laboratory Services (Healthcare)
Cytognos 25-Jul-2018 Buyout/LBO Diagnostic Equipment
DESTINA 02-Oct-2014 Later Stage VC Biotechnology
To view Vitro’s complete investments and acquisitions history, request access »

Vitro Exits (1)

Vitro’s most recent exit was on 25-Jul-2018 from Cytognos. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Cytognos 25-Jul-2018 Completed
  • 2 buyers
To view Vitro’s complete exits history, request access »

Vitro Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Recovid Solutions Sevilla, Spain 2020

Vitro FAQs

  • When was Vitro founded?

    Vitro was founded in 1989.

  • Where is Vitro headquartered?

    Vitro is headquartered in Sevilla, Spain.

  • What is the size of Vitro?

    Vitro has 225 total employees.

  • What industry is Vitro in?

    Vitro’s primary industry is Other Devices and Supplies.

  • Is Vitro a private or public company?

    Vitro is a Private company.

  • What is the current valuation of Vitro?

    The current valuation of Vitro is .

  • What is Vitro’s current revenue?

    The current revenue for Vitro is .

  • Who are Vitro’s investors?

    Headway Capital Partners and Buenavista Equity Partners have invested in Vitro.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »